Fujian Aonong Biological Technology Grouporp (SHSE:603363) Research & Development : ¥116 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Fujian Aonong Biological Technology Grouporp Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Fujian Aonong Biological Technology Grouporp's Research & Development for the three months ended in Mar. 2024 was ¥15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥116 Mil.

Fujian Aonong Biological Technology Grouporp Research & Development Historical Data

The historical data trend for Fujian Aonong Biological Technology Grouporp's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fujian Aonong Biological Technology Grouporp Research & Development Chart

Fujian Aonong Biological Technology Grouporp Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

72.85

65.36

113.88

161.67

148.86

Fujian Aonong Biological Technology Grouporp Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Research & Development	Get a 7-Day Free Trial															47.32	34.69	31.44	35.41	14.56

Fujian Aonong Biological Technology Grouporp Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥116 Mil.

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Fujian Aonong Biological Technology Grouporp Research & Development Related Terms

Thank you for viewing the detailed overview of Fujian Aonong Biological Technology Grouporp's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fujian Aonong Biological Technology Group Incorp Ltd (SHSE:603363) » Definitions » Research & Development

Traded in Other Exchanges

N/A

Address

Guanyinshan Operation Center, 12th Floor, Building 10, Siming District, Fujian Province, Xiamen, CHN, 361008

Website

http://www.aonong.com.cn

Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.

Executives

Wu You Lin	Directors, senior managers
Huang Hua Dong	Director
Wen Qing Qi	Supervisors
Huang Zu Yao	Director
Lai Jun	senior management
Ye Jun Biao	Director
Yang Jing Quan	senior management
Ding Neng Shui	Director
Luo Zuo Ming	senior management
Hong Yuan Xiang	senior management
Guo Si Hu	senior management
Wu Jun	Director
Huang Ze Sen	senior management
Hou Hao Feng	senior management
Li Hai Feng	senior management

Fujian Aonong Biological Technology Grouporp (SHSE:603363) Headlines

No Headlines